把我的钱还给我 我不玩了
02-20 18:39
接人的机会
Grail盘前暴跌47%,罪魁祸首是这些检测结果
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":534793842423416,"tweetId":"534793842423416","gmtCreate":1771583989467,"gmtModify":1771583991984,"author":{"id":4104232728043510,"idStr":"4104232728043510","authorId":4104232728043510,"authorIdStr":"4104232728043510","name":"把我的钱还给我 我不玩了","avatar":"https://static.tigerbbs.com/d22ff2fce1bb068e0233d32608d90c25","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.17","exceedPercentage":"60.76%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>接人的机会</p></body></html>","htmlText":"<html><head></head><body><p>接人的机会</p></body></html>","text":"接人的机会","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/534793842423416","repostId":1147942002,"repostType":2,"repost":{"id":"1147942002","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1771579965,"share":"https://www.laohu8.com/m/news/1147942002?lang=zh_CN&edition=full","pubTime":"2026-02-20 17:32","market":"us","language":"zh","title":"Grail盘前暴跌47%,罪魁祸首是这些检测结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1147942002","media":"老虎资讯综合","summary":"生物科技公司Grail盘前交易中股价暴跌47%,此前该公司癌症试验结果令投资者失望。Galleri是一种由Grail开发的血液检测,用于在癌症出现症状前筛查多种癌症。收盘后股价暴跌48%至52.25美元;截至周四收盘,该股在过去六个月已上涨逾200%。Grail于1月向美国食品药品监督管理局提交了上市前批准申请。公司补充称,提交材料中包含了NHS试验第一年的结果。Grail第四季度每股亏损2.44美元,好于预期;营收4360万美元,与华尔街预估基本一致。","content":"<html><head></head><body><p>2月20日周五,医疗公司 <a href=\"https://laohu8.com/S/GRAL\">GRAIL, Inc.</a> 在盘前交易中暴跌超47%,此前该公司癌症试验结果令投资者失望。</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/2529f7a720c0dcfbebfd4b67ba73cd63\" title=\"\" tg-width=\"517\" tg-height=\"157\"/></p><p>公司表示,在一项涵盖超过14.2万名50至77岁人群的英国国家医疗服务体系(NHS)试验中,其多癌种筛查检测Galleri未能带来“统计学显著”的三期和四期癌症减少。</p><p>Galleri是一种由Grail开发的血液检测,用于在癌症出现症状前筛查多种癌症。</p><p>不过,Grail称,在12种致命癌症的分组中,三期和四期癌症数量出现“有利趋势”的下降,同时早期癌症(通常较晚才被发现)的诊断数量有所增加。</p><p>但该试验最终未能实现其主要目标——在晚期癌症方面达到统计学显著下降。收盘后股价暴跌48%至52.25美元;截至周四收盘,该股在过去六个月已上涨逾200%。</p><p>Grail于1月向美国食品药品监督管理局(FDA)提交了上市前批准申请。公司补充称,提交材料中包含了NHS试验第一年的结果。</p><p>这家生物科技公司还在周四晚些时候公布了财报,但基本被试验结果所掩盖。Grail第四季度每股亏损2.44美元,好于预期;营收4360万美元,与华尔街预估基本一致。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grail盘前暴跌47%,罪魁祸首是这些检测结果</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrail盘前暴跌47%,罪魁祸首是这些检测结果\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2026-02-20 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>2月20日周五,医疗公司 <a href=\"https://laohu8.com/S/GRAL\">GRAIL, Inc.</a> 在盘前交易中暴跌超47%,此前该公司癌症试验结果令投资者失望。</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/2529f7a720c0dcfbebfd4b67ba73cd63\" title=\"\" tg-width=\"517\" tg-height=\"157\"/></p><p>公司表示,在一项涵盖超过14.2万名50至77岁人群的英国国家医疗服务体系(NHS)试验中,其多癌种筛查检测Galleri未能带来“统计学显著”的三期和四期癌症减少。</p><p>Galleri是一种由Grail开发的血液检测,用于在癌症出现症状前筛查多种癌症。</p><p>不过,Grail称,在12种致命癌症的分组中,三期和四期癌症数量出现“有利趋势”的下降,同时早期癌症(通常较晚才被发现)的诊断数量有所增加。</p><p>但该试验最终未能实现其主要目标——在晚期癌症方面达到统计学显著下降。收盘后股价暴跌48%至52.25美元;截至周四收盘,该股在过去六个月已上涨逾200%。</p><p>Grail于1月向美国食品药品监督管理局(FDA)提交了上市前批准申请。公司补充称,提交材料中包含了NHS试验第一年的结果。</p><p>这家生物科技公司还在周四晚些时候公布了财报,但基本被试验结果所掩盖。Grail第四季度每股亏损2.44美元,好于预期;营收4360万美元,与华尔街预估基本一致。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/516cbe31098a2a42f16da93a5544fbb1","relate_stocks":{},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147942002","content_text":"2月20日周五,医疗公司 GRAIL, Inc. 在盘前交易中暴跌超47%,此前该公司癌症试验结果令投资者失望。公司表示,在一项涵盖超过14.2万名50至77岁人群的英国国家医疗服务体系(NHS)试验中,其多癌种筛查检测Galleri未能带来“统计学显著”的三期和四期癌症减少。Galleri是一种由Grail开发的血液检测,用于在癌症出现症状前筛查多种癌症。不过,Grail称,在12种致命癌症的分组中,三期和四期癌症数量出现“有利趋势”的下降,同时早期癌症(通常较晚才被发现)的诊断数量有所增加。但该试验最终未能实现其主要目标——在晚期癌症方面达到统计学显著下降。收盘后股价暴跌48%至52.25美元;截至周四收盘,该股在过去六个月已上涨逾200%。Grail于1月向美国食品药品监督管理局(FDA)提交了上市前批准申请。公司补充称,提交材料中包含了NHS试验第一年的结果。这家生物科技公司还在周四晚些时候公布了财报,但基本被试验结果所掩盖。Grail第四季度每股亏损2.44美元,好于预期;营收4360万美元,与华尔街预估基本一致。","news_type":1,"symbols_score_info":{"GRAL":2}},"isVote":1,"tweetType":1,"viewCount":7,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/534793842423416"}
精彩评论